Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.
Lonardi S, Sobrero A, Rosati G, Di Bartolomeo M, Ronzoni M, Aprile G, Massida B, Scartozzi M, Banzi M, Zampino MG, Pasini F, Marchetti P, Cantore M, Zaniboni A, Rimassa L, Ciuffreda L, Ferrari D, Barni S, Zagonel V, Maiello E, Rulli E, Labianca R; TOSCA (Three or Six Colon Adjuvant) Investigators. Lonardi S, et al. Among authors: sobrero a. Ann Oncol. 2016 Nov;27(11):2074-2081. doi: 10.1093/annonc/mdw404. Epub 2016 Aug 29. Ann Oncol. 2016. PMID: 27573560 Free article. Clinical Trial.
[Adjuvant therapy of colon cancer. State of the art and future perspectives].
Barni S, Cascinu S, Foa P, Frontini L, Labianca R, Luporini G, Mandalà M, Martignoni G, Pancera G, Sobrero A, Zaniboni A. Barni S, et al. Among authors: sobrero a. Tumori. 1999 May-Jun;85(3):A1-6. doi: 10.1177/030089169908500315. Tumori. 1999. PMID: 10426137 Review. Italian. No abstract available.
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers.
Sobrero A, Zaniboni A, Frassineti GL, Aschele C, Guglielmi A, Giuliani R, Ravaioli A, Lanfranco C, Caroti C, Arnoldi E, Barni S, Gallo L, Pessi MA, Turci D, Cortesi E, Grossi F, Frontini L, Piazza E, Bruzzi P, Labianca R. Sobrero A, et al. Ann Oncol. 2000 Nov;11(11):1413-20. doi: 10.1023/a:1026527605389. Ann Oncol. 2000. PMID: 11142481 Free article. Clinical Trial.
Endpoints of medical treatment of colorectal cancer.
Sobrero A, Belvedere O, Ramello M, Aprile G, Rizzato S, Perlazzi R, Minisini A. Sobrero A, et al. Tumori. 2001 Jan-Feb;87(1 Suppl 1):S63-4. Tumori. 2001. PMID: 11300030 No abstract available.
Fatigue: a main component of anemia symptomatology.
Sobrero A, Puglisi F, Guglielmi A, Belvedere O, Aprile G, Ramello M, Grossi F. Sobrero A, et al. Semin Oncol. 2001 Apr;28(2 Suppl 8):15-8. doi: 10.1016/s0093-7754(01)90207-6. Semin Oncol. 2001. PMID: 11395847 Review.
Tamoxifen-induced total alopecia.
Puglisi F, Aprile G, Sobrero A. Puglisi F, et al. Among authors: sobrero a. Ann Intern Med. 2001 Jun 19;134(12):1154-5. doi: 10.7326/0003-4819-134-12-200106190-00029. Ann Intern Med. 2001. PMID: 11412069 No abstract available.
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).
Di Costanzo F, Sobrero A, Gasperoni S, Dogliotti L, Frassineti L, Falcone A, Lionetto R, Bruzzi P, Luppi G, Gallo L, Conte P, Comandone A, Turci D, Marzola M, Folco U, Pfanner E, Mestriner M, Boni C, Galli C, Tonato M, Rosso R; Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). Di Costanzo F, et al. Among authors: sobrero a. Ann Oncol. 2003 Sep;14(9):1365-72. doi: 10.1093/annonc/mdg359. Ann Oncol. 2003. PMID: 12954574 Free article. Clinical Trial.
298 results